Eva Nordström

1.7k total citations
30 papers, 1.3k citations indexed

About

Eva Nordström is a scholar working on Molecular Biology, Neurology and Hematology. According to data from OpenAlex, Eva Nordström has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Neurology and 8 papers in Hematology. Recurrent topics in Eva Nordström's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Nerve injury and regeneration (5 papers). Eva Nordström is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Multiple Myeloma Research and Treatments (7 papers) and Nerve injury and regeneration (5 papers). Eva Nordström collaborates with scholars based in Sweden, United States and Italy. Eva Nordström's co-authors include Eija Airaksinen, Agneta Herlitz, Peter Liljeström, Joakim Bergström, Martin Ingelsson, Lars Lannfelt, Veronica Lindström, Charli Eriksson, Margareta Lindén‐Boström and Kenneth Berglund and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Eva Nordström

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Nordström Sweden 20 318 256 193 191 161 30 1.3k
Ferenc Nagy Hungary 28 479 1.5× 343 1.3× 259 1.3× 258 1.4× 390 2.4× 170 3.0k
Barbara B. Mittleman United States 19 408 1.3× 413 1.6× 363 1.9× 113 0.6× 313 1.9× 32 2.5k
Enrico Parano Italy 23 262 0.8× 592 2.3× 381 2.0× 304 1.6× 60 0.4× 91 2.1k
Mikkel Steen Petersen Denmark 19 423 1.3× 81 0.3× 163 0.8× 165 0.9× 126 0.8× 63 1.2k
Philip Yates United Kingdom 21 142 0.4× 149 0.6× 87 0.5× 116 0.6× 111 0.7× 55 1.3k
Paolo Mariotti Italy 24 299 0.9× 265 1.0× 264 1.4× 239 1.3× 93 0.6× 68 1.4k
Banu Anlar Türkiye 28 761 2.4× 546 2.1× 137 0.7× 213 1.1× 250 1.6× 202 2.9k
Matti Iivanainen Finland 21 276 0.9× 163 0.6× 179 0.9× 102 0.5× 224 1.4× 50 1.4k
J Feingold France 27 145 0.5× 801 3.1× 395 2.0× 438 2.3× 117 0.7× 115 2.5k
Ana Cristina de Medeiros Ribeiro Brazil 25 87 0.3× 162 0.6× 182 0.9× 95 0.5× 507 3.1× 111 1.9k

Countries citing papers authored by Eva Nordström

Since Specialization
Citations

This map shows the geographic impact of Eva Nordström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Nordström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Nordström more than expected).

Fields of papers citing papers by Eva Nordström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Nordström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Nordström. The network helps show where Eva Nordström may publish in the future.

Co-authorship network of co-authors of Eva Nordström

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Nordström. A scholar is included among the top collaborators of Eva Nordström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Nordström. Eva Nordström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zachrisson, Olof, Malin Johannesson, Linda Söderberg, et al.. (2025). Exidavnemab binds to aggregated α-synuclein in human brains affected by α-synucleinopathies. Neurotherapeutics. 23(1). e00779–e00779.
2.
Bringhen, Sara, Torben Plesner, Ulf‐Henrik Mellqvist, et al.. (2021). Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1. British Journal of Haematology. 193(6). 1105–1109. 12 indexed citations
3.
Richardson, Paul G., Sara Bringhen, Torben Plesner, et al.. (2020). Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1–2 study. The Lancet Haematology. 7(5). e395–e407. 62 indexed citations
4.
Johannesson, Malin, Fredrik Eriksson, Werner Poewe, et al.. (2018). Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy. Frontiers in Neuroscience. 12. 452–452. 30 indexed citations
5.
Gustafsson, Gabriel, Veronica Lindström, Jinar Rostami, et al.. (2017). Alpha-synuclein oligomer-selective antibodies reduce intracellular accumulation and mitochondrial impairment in alpha-synuclein exposed astrocytes. Journal of Neuroinflammation. 14(1). 241–241. 38 indexed citations
6.
Berglund, Åke, Anders Ullén, Alla Lisyanskaya, et al.. (2015). First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies. Investigational New Drugs. 33(6). 1232–1241. 24 indexed citations
7.
8.
Lindström, Veronica, Therese Fagerqvist, Eva Nordström, et al.. (2014). Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice. Neurobiology of Disease. 69. 134–143. 106 indexed citations
9.
10.
Lindström, Veronica, Elisabet Ihse, Therese Fagerqvist, et al.. (2014). Immunotherapy Targeting α-Synuclein, with Relevance for Future Treatment of Parkinson‘s Disease and Other Lewy Body Disorders. Immunotherapy. 6(2). 141–153. 49 indexed citations
11.
Knudsen, Maria L., Daniel X. Johansson, Eva Nordström, et al.. (2013). The Adjuvant Activity of Alphavirus Replicons Is Enhanced by Incorporating the Microbial Molecule Flagellin into the Replicon. PLoS ONE. 8(6). e65964–e65964. 11 indexed citations
12.
Näslund, Tanja I., et al.. (2011). Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines. Virology Journal. 8(1). 36–36. 25 indexed citations
13.
Molarius, Anu, Kenneth Berglund, Charli Eriksson, et al.. (2009). Mental health symptoms in relation to socio-economic conditions and lifestyle factors – a population-based study in Sweden. BMC Public Health. 9(1). 302–302. 173 indexed citations
14.
Douagi, Iyadh, Cecilia Dayaraj, Mattias N.E. Forsell, et al.. (2005). Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles. Virology. 341(2). 190–202. 17 indexed citations
15.
Herlitz, Agneta, Eija Airaksinen, & Eva Nordström. (1999). Sex differences in episodic memory: The impact of verbal and visuospatial ability.. Neuropsychology. 13(4). 590–597. 139 indexed citations
16.
Herlitz, Agneta, Eija Airaksinen, & Eva Nordström. (1999). Sex differences in episodic memory: The impact of verbal and visuospatial ability.. Neuropsychology. 13(4). 590–597. 137 indexed citations
17.
Nordström, Eva, Erna Möller, & Manuchehr Abedi‐Valugerdi. (1998). Induction of IgG Rheumatoid Factor (RF) Production by Antibody–antibody (RF-like) Immune Complexes: the Role of T cells, Complement and Fcγ Receptors. Journal of Autoimmunity. 11(2). 131–140. 8 indexed citations
18.
19.
Johansson, Claes, et al.. (1990). A combined electromyographic and cineradiologic investigation in patients with defecation disorders. Diseases of the Colon & Rectum. 33(12). 1009–1013. 34 indexed citations
20.
Rosfors, Stefan, S. Bygdeman, & Eva Nordström. (1990). Assessment of Deep Venous Incompetence: A Prospective Study Comparing Duplex Scanning with Descending Phlebography. Angiology. 41(6). 463–468. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ferenc Nagy Breakdown of academic impact, for papers by Barbara B. Mittleman Breakdown of academic impact, for papers by Enrico Parano Breakdown of academic impact, for papers by Mikkel Steen Petersen Breakdown of academic impact, for papers by Philip Yates Breakdown of academic impact, for papers by Paolo Mariotti Breakdown of academic impact, for papers by Banu Anlar Breakdown of academic impact, for papers by Matti Iivanainen Breakdown of academic impact, for papers by J Feingold Breakdown of academic impact, for papers by Ana Cristina de Medeiros Ribeiro
Rankless by CCL
2026